✦ LIBER ✦

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma

✍ Scribed by Man-Fung Yuen; Ronnie Tung-Ping Poon; Ching-Lung Lai; Sheung-Tat Fan; Chung-Mau Lo; Ka-Wah Wong; Wai Man Wong; Benjamin Chun-Yu Wong

Book ID: 111721958
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 93 KB
Volume: 36
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2002.35071

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-acting octreotide versus placebo fo

Long-acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double-blind study

✍ Gerhild Becker; Hans-Peter Allgaier; Manfred Olschewski; Andreas Zähringer; Hube 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

Although numerous treatment modalities have been explored in patients with advanced HCC, the therapeutic options are still limited. Somatostatin has been shown to have antimitotic activity in endocrine as well as in a variety of nonendocrine tumors. Expression of somatostatin receptors is found in H

Treatment of advanced hepatocellular car

Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study

✍ Jean-Claude Barbare; Olivier Bouché; Franck Bonnetain; Laetitia Dahan; Catherine 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 346 KB

242 The role of long acting octreotide i

242 The role of long acting octreotide in treating patients with advanced hepatocellular cancer (HCC). A randomized placebo-controlled trial

✍ D. Dimitroulopoulos; D. Xinopoulos; K. Tsamakidis; A. Zisimopoulos; E. Andriotis 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Octreotide for advanced hepatocellular c

Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials

✍ Tian-Kang Guo; Xiang-Yong Hao; Bin Ma; Ke-Hu Yang; Yi-Ping Li; Hong-Ling Li; Yua 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 326 KB

281 Efficacy of long acting release octr

281 Efficacy of long acting release octreotide in patients with advanced hepatocellular carcinoma: A randomized multicenter phase III study

✍ C. Verslype; G. Verset; H. Reynaert; I. Borbath; P. Langlet; A. Vandebroek; M. P 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Sorafenib plus long-acting octreotide in

Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study

✍ S. Del Prete; R. Addeo; L. Maiorino; G. Cennamo; V. Montesarchio; L. Leo; V. Fai 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB